Winston S. Kirton

FDA Issues Guidance To Clarify Recommendations Regarding Timely Initiation Of Voluntary Recalls

FDA Issues Draft Guidance To Clarify Referencing Of The Terms "Device" And "Counterfeit Device"

FDLI's Enforcement, Litigation, And Compliance Conference: For The Drug, Device, Food, And Tobacco Industries

The Pandemic Blueprint For Improving Health Care Access

FDA Publishes Guidance On The Enhanced System Under The DSCSA Going Into Effect On November 27, 2023

FDA Interprets Terms Used In Definitions Of Suspect And Illegitimate Product Under The DSCSA

FDA Publishes Guidance On The Identification And Notification Of Suspect Products As Part Of The Implementation Of The Drug Supply Chain Security Act

DOJ Announces $22 Million False Claims Act Settlement With The University Of Miami For Provider-Based Rule Violations Involving Laboratory Tests

FDA Publishes Guidance On Remote Interactive Evaluations For Oversight Of Drug Manufacturing And Bioresearch Monitoring Facilities During The COVID-19 Public Health Emergency

FDA Conforms Regulations To Exclude Certain Software Functions From The Definition Of Device